Author

Eli Sprecher

Observed name: E Sprecher

Institutions: Tel Aviv University, Tel Aviv Sourasky Medical Center

Observed institutions: Tel Aviv University, Technion – Israel Institute of Technology, Tel Aviv Sourasky Medical Center, Rambam Health Care Campus, Stony Brook University Hospital, Yale University, Meyer Children's Hospital, Dana-Farber Cancer Institute, Beckman Coulter (United States)

OpenAlex ID: A5110033124

A novel missense mutation in SLC5A2 encoding SGLT2 underlies autosomal-recessive renal glucosuria and aminoaciduria

2004 · Daniella Magen, Eli Sprecher, et al. · Kidney International · 118

Sephardic origins revealed for rare skin disorder, recessive dystrophic epidermolysis bullosa, in individuals carrying the unique c.6527insC mutation

2025 · Emily Mira Warshauer, Paul A Maier, et al. · Journal of Medical Genetics · 1

P1-06-23: Changes in Gene Expression after One Dose of Trastuzumab (T) in HER2+ Breast Cancer Cell Lines Predict Novel Pathways of Response in HER2 Positive Early Stage Breast Cancer.

2011 · E Sprecher, K Lezon-Geyda, et al. · Cancer Research

Abstract PD07-08: Integrated Genomic Analysis before and after Brief Exposure to Trastuzumab (T): The11q13 and 17q12 Amplicons Are Associated with Response to T+Chemotherapy in Early Stage HER2 Positive Breast Cancer

2010 · LN Harris, Z Liu, et al. · Cancer Research

Works count: 4

Citation count: 119

H-index: 1

I10-index: 1